Artiva Biotherapeutics, Inc. (ARTV)
4.60
+0.07
(+1.55%)
USD |
NASDAQ |
Feb 20, 10:58
Artiva Biotherapeutics EPS Diluted (Quarterly) : -0.8794 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rocket Pharmaceuticals, Inc. | -0.4511 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.53M |
| Total Expenses (Quarterly) | 21.53M |
| Enterprise Value | -0.0886M |
| Earnings Yield | -70.61% |
| Normalized Earnings Yield | -70.61 |